NewsBenzingaSysmex T2 BPA EPS 0,10 $ ne répond pas à l’estimation de 0,11 $, chiffre d’affaires de 892,974 M$ dépasse l’estimation de 834,870 M$ Sysmex T2 BPA EPS 0,10 $ ne répond pas à l’estimation de 0,11 $, chiffre d’affaires de 892,974 M$ dépasse l’estimation de 834,870 M$ Benzinga 2026.11.10 08:46 (GMT+0) Open on Benzinga Other news StoneX Maintains Buy on Rivian Automotive, Lowers Price Target to $20 Amer Sports Unleashes $1 Billion Buyback, Raises 2026 Outlook EXCLUSIVE: Tesla Still Rules Leveraged ETFs, but Anthropic IPO and Micron’s Rise Signal What’s Next StoneX Reiterates Hold on iQIYIto Hold StoneX Maintains Buy on Baidu, Lowers Price Target to $125 Veru Presents New Results At ObesityWeek; Adding Enobosarm Preserved Lean Mass And Stair Climb Physical Function In Older Patients ≥65 Years With Obesity Receiving Semaglutide
Veru Presents New Results At ObesityWeek; Adding Enobosarm Preserved Lean Mass And Stair Climb Physical Function In Older Patients ≥65 Years With Obesity Receiving Semaglutide